OptimizeRx Unveils a Significant Enhancement to its Omni-channel Healthcare Engagement Platform
26 sept. 2023 08h00 HE
|
OptimizeRx Corporation
WALTHAM, Mass., Sept. 26, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and...
OptimizeRx Expands AI Powered Omnichannel Platform
24 août 2023 08h00 HE
|
OptimizeRx Corporation
WALTHAM, Mass., Aug. 24, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Reports Second Quarter 2023 Financial Results
14 août 2023 16h01 HE
|
OptimizeRx Corporation
– RWD.AI-enabled portion of the core business sees 186% YOY growth during the first half of 2023 – Non-core business is lagging – Total revenue of $13.8 million – GAAP net loss...
OptimizeRx Sets Second Quarter 2023 Conference Call for August 14, 2023 at 4:30 p.m. ET
31 juil. 2023 08h01 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., July 31, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx’s CEO Provides 2023 Midyear Strategic Update
24 mai 2023 07h30 HE
|
OptimizeRx Corporation
A leading suite of pharma tech solutions combined with deep brand penetration is driving revenue growth, resulting in improved profitability and KPIs through the remainder of 2023 and beyondWith a...
OptimizeRx’s Karina Castagna Named One of the 2023 PM360 ELITE 100
18 mai 2023 08h01 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., May 18, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx to Participate in Upcoming Investor Conferences
15 mai 2023 08h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., May 15, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Reports First Quarter 2023 Financial Results
10 mai 2023 16h01 HE
|
OptimizeRx Corporation
Total revenue of $13.0 millionGAAP net loss per share of $(0.37)Non-GAAP net loss per share of $(0.09) ROCHESTER, Mich., May 10, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq:...
Surveyed Physicians Spell Out Preferences for Data-driven, Omnichannel Content That Delivers Clinical Relevance
02 mai 2023 08h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., May 02, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...
OptimizeRx Sets First Quarter 2023 Conference Call for May 10, 2023at 4:30 p.m. ET
26 avr. 2023 08h00 HE
|
OptimizeRx Corporation
ROCHESTER, Mich., April 26, 2023 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of point-of-care technology solutions helping patients start and stay on...